World Alzheimer’s Day
MADIA fourth project meeting
MADIA 6 Months project meeting
A scientific team from IMEC received funding from Chan Zuckerberg Initiative (CZI) to work on Neurodegenerative Diseases. The team plans to create a new chip to study the mechanisms of Parkinson’s disease.
Our project partner Scriba Nanotecnologie has presented MADIA project at Bioanalitica 2018 (Bologna, Italy). The Congress is organized yearly by the Analytical Chemistry Division of the Italian Chemical Society and it provides an opportunity for all researchers in the field to meet and debate key topics. The different aspects of Analytical Chemistry are covered, from the traditional sectors to the most innovative ones.
September 21st every year is World Alzheimer’s Day around the world. This is an international campaign aimed at raising awareness and challenge the common stigma that surrounds Alzheimer related dementia. Alzheimer’s is a progressive disease that impairs memory and other mental functions. It is the most common form of dementia that generalizes memory loss and loss of other essential cognitive abilities that are serious enough to interfere with an individual’s daily life.
This article originally appeared on www.gatesnotes.com
The fourth project meeting of MADIA has started on 4th July 2018 in Brighton (UK), organized by the University of Brighton.
Researchers at CNR Nanotec, MADIA project partner, pubished an interesting study on Development of a lab-on-a-chip method for rapid assay of Xylella fastidiosa.
The urgent need for early diagnosis in neurodegenerative disease, namely Alzheimer's s disease and Parkinson's disease, calls for multidisciplinary approach in order to tailor diagnostic and therapeutical tools on different diseases presentation at the early stage of the diseases.
"The US-based pharmaceutical giant said it would be ending its neuroscience discovery programmes following a review, and 300 jobs would be lost. The Alzheimer's Society called the news "disappointing" and a "heavy blow" to those living with dementia. "
Researchers at the MRC Laboratory of Molecular Biology (LMB) have, for the first time, revealed the atomic structures of one of the two types of the abnormal filaments which lead to Alzheimer's disease.
The 6 Months project meeting of MADIA was held on 6-7 July 2017 in Santiago de Compostela (Spain), organized by Universidad De Santiago De Compostela (USC) and Servizo Galego De Saúde (SERGAS).